NextGen Jane, a diagnostics startup focused on reproductive health, has raised a $9 million Series A round led by Material Impact, with the participation of Access Industries, Viking Global Investors, Liminal Ventures, and several angels.
The UK government has announced a new National Genomic Healthcare Strategy which sets out how the UK can become the global leader in genomic healthcare.
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
DNAnexus, the bioinformatics company, has closed a $68 million financing round from a combination of existing investors, including GV, Foresite Capital, TPG Biotech, WuXi NextCODE and Claremont Creek Ventures, and debt and equity from Innovatus Capital Partners.
Genomics England has selected QIAGEN to provide bioinformatic support to the NHS Genomic Medicine Service and its national network of Genomic Laboratory Hubs for 5 million genome project.
The UK's NHS has today published its Long Term Plan, which sets out a vision to save half a million lives 'with practical action on major killer conditions and investment in world class, cutting edge treatments' over the next decade. At the heart of the plans is the use of technology for a wide range of purposes from telehealth to genomic screening.
Research carried out during the 2018 Lassa fever outbreak in Nigeria used rapid, portable genomic sequencing technology to identify viruses without prior knowledge of the cause of disease. This enabled researchers to allay fears and direct the public health interventions to limit the spread of the virus and help to protect more people from disease.